Home / Blog / The Week’s 10 Biggest Funding Rounds: $400 million For…
Tech News

The Week’s 10 Biggest Funding Rounds: $400 million For Neurotech Leads

Based in Alameda, California, the brain-computer interface developer expands its cumulative balance sheet beyond 900 million dollars in total funding to date.

By Dillip Chowdary • Nov 20, 2026 • Source: Crunchbase News

The Week’s 10 Biggest Funding Rounds: $400 million For Neurotech Leads
Image: Crunchbase News

At a glance

Lead deal
Science $400M Series D
Top valuation
Model ML $1.5B Series B
Global leader
Isomorphic Labs $5B Series C
Tracking window
Nov. 14-20, 2026
Mega-rounds
8 U.S. deals at $100M or more

United States venture activity recorded substantial capital deployments for the mid-November 2026 cycle, led by brain-computer interface developer Science raising 400 million dollars in fresh Series D financing. Detailed tracking in Crunchbase News's report showed that eight domestic companies closed private financing tranches of 100 million dollars or more during the week.

This dispatch outlines the ten largest private equity and venture transactions across enterprise software, life sciences, neural engineering, and advanced manufacturing. It serves institutional investors, corporate operators, and technical founders tracking valuation benchmarks, investor syndicates, and late-stage capital availability across growth markets.

01Alameda neural engineering and brain interfaces

Science secured 400 million dollars in Series D capital to advance its neural engineering programs and clinical-stage hardware platforms. Based in Alameda, California, the brain-computer interface developer expands its cumulative balance sheet beyond 900 million dollars in total funding to date. The transaction establishes the enterprise as the primary capital recipient among domestic technology startups during the weekly tracking window.

The company concentrates engineering resources on bio-compatible microelectronics and neural decoding architectures designed to restore physiological functions. Substantial late-stage backing signals sustained investor interest in complex clinical hardware despite volatility in public equity indices. The expanded capital base provides operational runway for ongoing clinical evaluation, laboratory manufacturing, and regulatory compliance milestones.

Substantial capital concentration in neurotechnology reflects specialized laboratory infrastructure requirements and multi-year trial timelines. Science continues to deploy resources toward neural interface assemblies capable of processing high-density biological signals. The nine-hundred-million-dollar milestone positions the team to compete directly across advanced medical device development and computational biology sectors.

02Financial analytics platforms and self improving systems

Model ML closed 250 million dollars in Series B funding at a 1.5 billion dollar valuation, elevating the three-year-old enterprise into unicorn status. Operating from dual headquarters in New York and London, the platform delivers specialized artificial intelligence workflows tailored for financial institutions and professional service firms. Growth equity firm General Atlantic and fintech specialist QED Investors co-led the transaction.

In Palo Alto, artificial intelligence developer Noeri emerged from stealth by securing 110 million dollars in initial financing led by Menlo Ventures. Founded by Stanford University computer science professors, the venture designs self-improving machine learning systems targeted at corporate enterprises and technical research laboratories. The financing establishes direct institutional backing for foundational optimization models intended to streamline computational research tasks.

Both funding rounds demonstrate institutional demand for vertically tailored corporate intelligence and autonomous technical infrastructure. Investors prioritized teams offering domain-specific models capable of auditing complex financial data or refining proprietary algorithmic parameters. The dual capital infusions highlight how enterprise software budgets continue migrating toward autonomous agent architectures and verified computational pipelines.

03Bone marrow therapies and electrical ablation

Advertisement

Tech Pulse Daily

Get tomorrow's pulse first

Join engineers who read Tech Pulse before stand-up. Free, weekday mornings.

Redwood City-based Galvanize Therapeutics collected 130 million dollars in Series D financing led by HealthQuest Capital. The medical device manufacturer utilizes pulsed electric field ablation platforms to address clinical targets across surgical oncology and persistent chronic conditions. The capital deployment accelerates commercial integration and procedural expansion across specialized hospital systems and outpatient surgical suites.

Biopharmaceutical venture Marrow Therapeutics formally launched from Watertown, Massachusetts, disclosing 173 million dollars in combined early-stage backing. The company develops targeted therapies directed at bone marrow tissues to resolve severe hematological disorders. Orbimed directed the 120 million dollar Series B round, following a 53 million dollar Series A syndicated by Scion Life Sciences and venBio.

San Diego biotechnology entrant Seawolf Therapeutics emerged from stealth mode, announcing 100 million dollars in aggregate funding to date. The entity is advancing a specialized DNA delivery vehicle designed to transport therapeutic payloads efficiently into cellular targets. Life science backers Versant Ventures, MPM BioImpact, and Novartis Venture Fund led the syndicated financing tranche.

04Space computing infrastructure and critical metals

General Flash raised 128 million dollars across combined seed and Series A tranches to commercialize a novel synthesis process for producing critical industrial metals. Simultaneously, Denver-based Ramon.Space completed a 124 million dollar Series B round led by PSG to expand space computing infrastructure. The capital supports space-resilient computational hardware engineered to process sensor data directly within orbital environments.

Silicon Valley physical automation firm BrightAI finalized 97 million dollars in new capital led by Smith Point Capital. The company deploys autonomous sensors, unmanned aerial systems, and robotic systems to provide continuous operational observability across municipal water utilities, power grids, and energy distribution networks. The platform aggregates physical telemetry to prevent utility infrastructure failures.

In Kansas City, automotive software platform Vincue closed 93 million dollars in growth equity led by Wavecrest Growth Partners. The startup delivers a vehicle lifecycle intelligence system that unifies inventory sourcing, appraisal valuation, reconditioning tracking, and dealer management workflows. The platform helps regional dealerships optimize capital allocation across physical automotive inventory.

05Overseas drug discovery and venture sentiment

Beyond domestic boundaries, London-based artificial intelligence biotechnology firm Isomorphic Labs secured five billion dollars in Series C capital, marking the largest overall transaction of the weekly cycle. Operating additional facilities in Massachusetts and Switzerland, the five-year-old enterprise deploys algorithmic architectures toward novel pharmaceutical discovery. Global venture firms Greenoaks and Sequoia Capital led the massive financing syndicate.

The private capital expansion coincided with significant public market crosscurrents, highlighted by artificial intelligence developer Anthropic completing its initial public offering. Despite that landmark public listing, broader technology equities experienced steep pricing declines throughout the trading week. Analysts noted that persistent negative sentiment in publicly traded equities could eventually exert downward valuation pressure across late-stage private rounds.

Note: Crunchbase tracked announced equity transactions completed by American entities between November 14 and November 20, 2026. While database records capture the vast majority of institutional financings, reporting time lags occasionally occur when corporate filings or transaction announcements finalize late in the tracking cycle.

Frequently asked questions

Which company raised the largest U.S. funding round this week?

Brain-computer interface and neural engineering startup Science secured $400 million in Series D funding, bringing its total funding to more than $900 million.

What was the valuation of Model ML following its funding round?

Model ML reached a $1.5 billion valuation after securing $250 million in Series B financing led by General Atlantic and QED Investors.

What was the largest international venture capital deal announced?

UK-based AI drug discovery startup Isomorphic Labs raised $5 billion in Series C funding led by Greenoaks and Sequoia Capital.

How many American startups secured funding rounds of at least $100 million?

Eight American companies announced venture or growth funding of $100 million or more during the week of November 14 to November 20, 2026.

Sources

Dillip Chowdary

Author

Dillip Chowdary

Writes Tech Bytes coverage of AI, engineering, and the tools that actually ship. Editor of Tech Pulse Daily.

Related on Tech Bytes

Advertisement

5-min tech signal

Weekday briefing for engineers who skip the noise.

No spam · Unsubscribe anytime

Advertisement

✈️ CareerPilot

Your AI job-search copilot

Match your resume against live Ashby, Greenhouse & Lever openings — fit scores, job-specific resume optimization and email alerts.

Find matching jobs →

Free Tools

Browse all tools →